HSA Approval

DHATIFEN TABLET 1 mg

Approval Number

SIN07601P

Drug Name

Product Name

DHATIFEN TABLET 1 mg

Approval Date

January 5, 1994

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

R06AX17

ATC Item Name

ketotifen

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PT ACTAVIS INDONESIA

Active Ingredients

Ingredient Name

KETOTIFEN HYDROGEN FUMARATE 1.38mg EQV KETOTIFEN

Strength

1 mg

Drug MonographKetotifen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

DHATIFEN TABLET 1 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

DHATIFEN TABLET 1 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal